Tea polyphenols inhibit IL‐6 production in tumor necrosis factor superfamily 14‐stimulated human gingival fibroblasts
- 22 July 2010
- journal article
- research article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 54 (S2) , S151-S158
Abstract
IL‐6 is well recognized to be a potent bone resorptive agent and thus in the development of periodontal disease. Epigallocatechin gallate (EGCG) and epicatechin gallate (ECG), the major catechins in green tea, and theaflavin‐3,3′‐digallate (TFDG), polyphenol in black tea, have multiple beneficial effects, but the effects of catechins and theaflavins on IL‐6 production in human gingival fibroblasts (HGFs) are not known. In this study, we investigated the mechanisms by which EGCG, ECG, and TFDG inhibit tumor necrosis factor superfamily 14 (TNFSF14)‐induced IL‐6 production in HGFs. We detected TNFSF14 mRNA expression in human diseased periodontal tissues. TNFSF14 increased IL‐6 production in HGFs in a concentration‐dependent manner. EGCG, ECG, and TFDG prevented TNFSF14‐mediated IL‐6 production in HGFs. EGCG, ECG, and TFDG prevented TNFSF14‐induced extracellular signal‐regulated kinase (ERK), c‐Jun N‐terminal kinase (JNK), and nuclear factor‐κB activation in HGFs. Inhibitors of ERK, JNK, and nuclear factor‐κB decreased TNFSF14‐induced IL‐6 production. In addition, EGCG, ECG, and TFDG attenuated TNFSF14 receptor expression on HGFs. These data provide a novel mechanism through which the green tea and black tea polyphenols could be used to provide direct benefits in periodontal disease.Keywords
Funding Information
- Grant-in-Aid for Young Scientists (21792123)
This publication has 29 references indexed in Scilit:
- Cytokines differentially regulate CXCL10 production by interferon‐γ‐stimulated or tumor necrosis factor‐α‐stimulated human gingival fibroblastsJournal of Periodontal Research, 2009
- Adrenomedullin suppresses tumour necrosis factor alpha-induced CXC chemokine ligand 10 production by human gingival fibroblastsClinical and Experimental Immunology, 2008
- Epigallocatechin-3-O-gallate inhibits TNFα-induced monocyte chemotactic protein-1 production from vascular endothelial cellsLife Sciences, 2008
- CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblastsClinical and Experimental Immunology, 2007
- (−)‐Epigallocatechin gallate suppresses endothelin‐1‐induced interleukin‐6 synthesis in osteoblasts: Inhibition of p44/p42 MAP kinase activationFEBS Letters, 2007
- Epigallocatechin-3-Gallate Inhibits Secretion of TNF-α, IL-6 and IL-8 through the Attenuation of ERK and NF-κB in HMC-1 CellsInternational Archives of Allergy and Immunology, 2006
- Protection from experimental colitis by theaflavin‐3,3′‐digallate correlates with inhibition of IKK and NF‐κB activationBritish Journal of Pharmacology, 2006
- Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxinClinical and Experimental Immunology, 2005
- Nuclear Factor-κB-Independent Regulation of Lipopolysaccharide-Mediated Interleukin-6 BiosynthesisBiochemical and Biophysical Research Communications, 2002
- Protein Expression and Functional Difference of Membrane-Bound and Soluble Receptor Activator of NF-κB Ligand: Modulation of the Expression by Osteotropic Factors and CytokinesBiochemical and Biophysical Research Communications, 2000